Drugdiscovery >> Clinical Trials >> News
3900
Views
GSK has ended the trials of its new lung cancer treatment - drugdiscovery.com
GSK has ended the trials of its new lung cancer treatment - drugdiscovery.com


Phase 3 trial of its MAGE-A3 was reported to be finished by GlaxoSmithKline. They say it is impossible to make sure that the drug is effective against non-small-cell lung cancer.
Read More >>


Tags: GSK clinical trial., MAGE-A3, lung cancer, lung cancer drug, lung cancer drug development - April 4, 2014
Related Articles
4116
Views
Merck continues the clinical development of tecemotide for lung cancer Merck continues the clinical development of tecemotide for lung cancer
Tecemotide (also known as L-BLP25), an investigational MUC1 antigen-specific cancer immunotherapy will be tested in a new Phase 3 trial called START for patients with unresectable, locally advanced S Read More >>

Tags: Merck, tecemotide, lung cancer, non-small cell lung cancer, immunotherapy

19791
Views
Lilly’s experimental lung cancer drug successful in phase III clinical trial Lilly’s experimental lung cancer drug successful in phase III clinical trial
Eli Lilly & Co. announced in a press release that necitumumab (IMC-11F8), in combination with gemcitabine and cisplatin, as first-line treatment for stage IV squamous cell non-small cell lung cancer Read More >>

Tags: Eli Lilly, necitumumab, advanced lung cancer, new drug,experimental drug, stage IV, squamous cell non-small cell lung cancer

2858
Views
Lilly’s cancer drug unsuccessful in breast cancer trial but shows promise in gastric cancer treatment Lilly’s cancer drug unsuccessful in breast cancer trial but shows promise in gastric cancer treatment
Eli Lilly’s investigational drug ramucirumab, missed its main goal in a late-stage study in patients with advanced breast cancer. The drug performed better in a separate study in patients with advan Read More >>

Tags: Eli Lilly, Lilly, investigational drug, clinical trials, ramucirumab, breast cancer, gastric cancer

3220
Views
Cancer research UK and its phamraceutical partner gain success Cancer research UK and its phamraceutical partner gain success
The clinical trial of Cancer research UK and its partners, such as AstraZeneca and Pfizer proved to be an outstanding success. The promising clinical trials offer a new help for lung cancer treatment. Read More >>

Tags: lung cancer, treatment, cancer research, cancer research UK

3960
Views
The results of linagliptin safety trials in patients with type 2 diabetes The results of linagliptin safety trials in patients with type 2 diabetes
Eli Lilly and Boehringer Ingelheim presented the results from two pooled analyses of data from placebo-controlled clinical trials, which examined the safety of the linagliptin in adults with type 2 di Read More >>

Tags: lingliptin, type 2 diabetes, safety, clinical trials, Eli Lilly

2816
Views
Clinical Trials: too slow for dying patients? Clinical Trials: too slow for dying patients?
Speed of clinical trials are sometimes too slow for dying patients. What we can do to speed up the process and enable patients to get the medicine on time? Can anything end the lethally slow process? Read More >>

Tags: process, patients, clinical trials

5543
Views
Afrezza inhaled insulin successful in Phase III trials Afrezza inhaled insulin successful in Phase III trials
MannKind’s inhaled insulin Afrezza showed clearly positive results in Phase III studies on Type 1 and Type 2 diabetes. The new drug application will be submitted to the FDA early in the fourth qua Read More >>

Tags: MannKind, inhaled insulin, Afrezza, clinical trials,type 1, type 2, diabetes

4314
Views
Ventrus’ drug for anal fissures shows positive clinical results Ventrus’ drug for anal fissures shows positive clinical results
Diltiazem hydrochloride 2% cream (VEN 307) has been successful in two clinical dermal safety studies and one pharmacokinetic (PK) study. This paves way to new drug application (NDA) for VEN 307 as a t Read More >>

Tags: Ventrus, VEN 307, anal fissures, cream, new treatment, clinical trials

4031
Views
Psoriasis spray successful in early clinical trials Psoriasis spray successful in early clinical trials
Lipidor announced that its Akvano/calcipotriol spray formulation for the treatment of psoriasis vulgaris showed effective in a phase 1/2a study. Read More >>

Tags: Lipidor, akvano/calcipotriol spray formulation, calcipotriol, spray, treatment, psoriasis, clinical trial

7727
Views
Promising results of Reolysin in Phase 2 clinical trial in patients with squamous cell carcinoma of the lung Promising results of Reolysin in Phase 2 clinical trial in patients with squamous cell carcinoma of the lung
Oncolytics Biotech’s drug Reolysin, used in combination with carboplatin and paclitaxel, has shown high tumor shrinkage in patients with metastatic or recurrent squamous cell carcinoma of the lung Read More >>

Tags: Reolysin, clinical trial, squamous cell carcinoma of the lung, SCCLC, Oncolytics Biotech

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013